Rongyisuan is described in the article as a Chinese tax and accounting startup. The report says GGV Capital led a Series A+ funding round of nearly 100 million yuan (about $14 million) in the company. The financing was reported as a Series A+. The article names GGV Capital as the lead investor and does not list other participating investors. The piece does not disclose deal terms, instrument breakdown beyond the Series A+ label, or operating metrics for Rongyisuan. The same report also noted that Beijing-based Hugo Biotech raised nearly 100 million yuan in its first funding round.

Total raised

$14M

Funding rounds

1

Latest round

Series A

Latest activity

Feb 2020